Wellbutrin Antitrust Suit To Proceed On Most Claims
A suit filed by a group of direct purchasers of Wellbutrin XL against Biovail Corp. and GlaxoSmithKline PLC alleging that the two engaged in anti-competitive conduct in a patent fight over...To view the full article, register now.
Already a subscriber? Click here to view full article